Concept information
Preferred term
Dipeptidyl-Peptidase IV Inhibitors
Type
-
mesh:Descriptor
Definition
- Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release.
Broader concept
Entry terms
- Dipeptidyl Peptidase 4 Inhibitor
- Dipeptidyl-Peptidase 4 Inhibitor
- Dipeptidyl-Peptidase 4 Inhibitors
- Dipeptidyl-Peptidase IV Inhibitor
- DPP-4 Inhibitor
- DPP4 Inhibitor
- DPP-4 Inhibitors
- DPP4 Inhibitors
- DPP-IV Inhibitor
- DPP-IV Inhibitors
- Gliptin
- Gliptins
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- analysis (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
In other languages
-
French
-
Gliptines
-
Inhibiteurs de la dipeptidyl-peptidase de type 4
URI
http://data.loterre.fr/ark:/67375/JVR-NH96NWS6-9
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}